未登录 分享 收藏
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi- Institutional Based survey of Adjuvant and fi rst-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) Reni, M.; Milella, M.; Bergamo, F.; Di Marco, M.; Giommoni, E.; Cardellino, G. G.; Cavanna, L.; Bonomi, M.; Zustovich, F.; Bozzarelli, S.; Salmaso, F.; Spada, M.; Orsi, G.; Macchini, M.; Insolda, J.; Procaccio, L.; Santoni, A.; De Simone, I.; Caldirola, L.; Galli, F.; Pinto, C. 分享 收藏
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey 意大利医学肿瘤学会（AIOM）加里波第调查中转移性队列的生存分析 Reni, M.; Giommoni, E.; Bergamo, F.; Cavanna, L.; Simionato, F.; Spada, M.; Di Marco, M.; Bernardini, I.; Cordio, S. S.; Latiano, T.; Spallanzani, A.; Silvestris, N.; Cardellino, G. G.; Bonomi, M.; Milella, M.; Luchena, G.; Tamburini, E.; Macchini, M.; Orsi, G.; Modesti, M.; Procaccio, L.; Santoni, A.; De Simone, I.; Caldirola, L.; Galli, F.; Pinto, C. 分享 收藏
Non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) guideline application in real-world: MultiInstitutional based survey of adjuvant and first-line pancreatic ductal adenocarcinoma treatment in Italy (GARIBALDI) Pinto, C.; Milella, M.; Bergamo, F.; Di Marco, M. C.; Cardellino, G. G.; Cavanna, L.; Giommoni, E.; Zustovich, F.; Bonomi, M.; Bozzarelli, S.; Vicario, G.; Parlagreco, E.; Frassineti, G. L.; Macchini, M.; Orsi, G.; Santoni, A.; Caldirola, L.; De Simone, I.; Reni, M. 分享 收藏
Krukenberg Tumor Related to Gallbladder Cancer in a Young Woman: A Case Report and Review of the Literature 年轻女性胆囊癌相关的Krukenberg肿瘤1例报告并文献复习 Grizzi, Giulia; Ghidini, Michele; Ratti, Margherita; D'Ercole, Marianna; Tanzi, Giulia; Abbiati, Annalisa; Celotti, Andrea; Spada, Daniele; Baiocchi, Gian Luca; Bonomi, Maria 分享 收藏
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies 胃食管腺癌的抗Claudin治疗: 主流和即将到来的策略 Grizzi, Giulia; Venetis, Kostantinos; Denaro, Nerina; Bonomi, Maria; Celotti, Andrea; Pagkali, Antonia; Hahne, Jens Claus; Tomasello, Gianluca; Petrelli, Fausto; Fusco, Nicola; Ghidini, Michele 分享 收藏
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma Canova, S.; Ceresoli, G. L.; Grosso, F.; Zucali, P. A.; Gelsomino, F.; Pasello, G.; Mencoboni, M.; Rulli, E.; Galli, F.; De Simone, I.; Carlucci, L.; De Angelis, A.; Belletti, M.; Bonomi, M.; D'Aveni, A.; Perrino, M.; Bono, F.; Cortinovis, D. L. 分享 收藏
分享 收藏
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer 寡进展型EGFR突变非小细胞肺癌中酪氨酸激酶抑制剂与放疗相关的进展后生存结果 Rossi, Sabrina; Finocchiaro, Giovanna; Di Noia, Vincenzo; Bonomi, Maria; Cerchiaro, Eleonora; De Rose, Fiorenza; Franceschini, Davide; Navarria, Pierina; Ceresoli, Giovanni Luca; Beretta, Giordano Domenico; D'Argento, Ettore; Scorsetti, Marta; Santoro, Armando; Toschi, Luca 分享 收藏
Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors Rossi, Sabrina; Toschi, Luca; Finocchiaro, Giovanna; Di Noia, Vincenzo; Bonomi, Maria; Cerchiaro, Eleonora; Ceresoli, Giovanni Luca; Beretta, Giordano Domenico; D'Argento, Ettore; Santoro, Armando 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience Bonomi, M.; Bonomi, L.; Sauta, M. G.; Bettini, A. C.; Squadroni, M.; Brena, F.; Cerchiaro, E.; Ripa, C.; Salvini, P.; Beretta, G. D.; Tondini, C.; Ceresoli, G. L. 分享 收藏
Weekly cisplatin, leucovorin and 5Fluorouracile (PFL) as first line chemotherapy in selected patients with advanced gastric cancer Squadroni, M.; Brena, F.; Cerchiaro, E.; Bonomi, M.; Sauta, M. G.; Ripa, C.; Ceresoli, G.; Salvini, P.; Beretta, G. 分享 收藏
分享 收藏
分享 收藏
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer Rayson, Daniel; Lupichuk, Sasha; Potvin, Kylea; Dent, Susan; Shenkier, Tamara; Dhesy-Thind, Sukhbinder; Ellard, Susan L.; Prady, Catherine; Salim, Muhammad; Farmer, Patricia; Allo, Ghasson; Tsao, Ming-Sound; Allan, Alison; Ludkovski, Olga; Bonomi, Maria; Tu, Dongsheng; Hagerman, Linda; Goodwin, Rachel; Eisenhauer, Elizabeth; Bradbury, Penelope 分享 收藏
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 无进展生存期作为晚期肾细胞癌靶向药物的随机临床试验的主要终点。与总体生存、基准和功率分析的相关性 Bria, Emilio; Massari, Francesco; Maines, Francesca; Pilotto, Sara; Bonomi, Maria; Porta, Camillo; Bracarda, Sergio; Heng, Daniel; Santini, Daniele; Sperduti, Isabella; Giannarelli, Diana; Cognetti, Francesco; Tortora, Giampaolo; Milella, Michele 分享 收藏
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials Bria, Emilio; Carbognin, Luisa; Furlanetto, Jenny; Pilotto, Sara; Bonomi, Maria; Guarneri, Valentina; Vicentini, Cecilia; Brunelli, Matteo; Nortilli, Rolando; Pellini, Francesca; Sperduti, Isabella; Giannarelli, Diana; Pollini, Giovanni Paolo; Conte, Pierfranco; Tortora, Giampaolo 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
